9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

Estimated reading time: < 1 min

Condition: Ovarian Cancer

Estimated Enrollment: 200

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Recruiting

Study Results: No Results Available

Outcome Measures: measure treatment response to HIPEC and tumor debulking,  Toxicity Monitoring,  ,

Interventions: HIPEC: MMC 30mg @ T0, 10mg @ T45min, HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0

Phase:

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: None (Open Label),Primary Purpose: Treatment

Primary Completion Date: January 2022

Completion Date: January 2022

Last  Posted Date: April 16, 2019

Location: James Lilja, Los Gatos, California, United States

Website Link: https://ClinicalTrials.gov/show/NCT02349958

Was this article helpful?
Dislike 0